96071-56-6Relevant academic research and scientific papers
The first synthesis of the antiangiogenic homoisoflavanone, cremastranone
Lee, Bit,Basavarajappa, Halesha D.,Sulaiman, Rania S.,Fei, Xiang,Seo, Seung-Yong,Corson, Timothy W.
, p. 7673 - 7677 (2014)
An antiangiogenic homoisoflavanone, cremastranone, was synthesized for the first time. This scalable synthesis, which includes selective demethylation, could be used to develop lead molecules to treat angiogenesis-induced eye diseases. Synthetic cremastra
Novel homoisoflavanone derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating ischemic brain damage and multiple sclerosis containing the same as an active ingredient
-
Paragraph 0419-0421, (2018/07/14)
The present invention relates to: a homoisoflavanone compound; a manufacturing method thereof; and a pharmaceutical composition for preventing or treating ischemic brain damage and multiple sclerosis containing the homoisoflavanone compound as an active i
COMPOUNDS FOR TREATMENT OF ANGIOGENESIS-MEDIATED DISEASES
-
Paragraph 0135; sheet 3, (2014/12/09)
Synthetic cremastranone and cremastranone analogs are disclosed. Additionally, methods for synthesizing cremastranone and cremastranone analogs are disclosed. Methods of treating ocular neovascularization disorders and treating angiogenesis-mediated disease are also disclosed.
Synthesis of 5,4'-Dihydroxy-7,8,3',5'-Tetramethoxyflavone and Two New Isomeric Pentaoxygenated Flavanones Isolated from Lepidium sativum and Vitex negundo
Chandra, S.,Babber, Sunanda
, p. 82 - 84 (2007/10/02)
The structures proposed for the new naturally occuring hexaoxygenated flavone as 5,4'-dihydroxy-7,8,3',5'-tetramethoxyflavone (1a) and of two new pentaoxygenated flavanones as 5,3'-dihydroxy-7,8,4'-trimethoxyflavanone (2) and 5,3'-dihydroxy-6,7,4'-trimeth
